Status:
COMPLETED
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
Lead Sponsor:
Photocure
Conditions:
Bladder Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The study is intended to investigate whether the improved initial detection and resection of bladder cancer lesions in patients with non-muscle invasive bladder cancer with Hexvix (Cysview) fluorescen...
Detailed Description
A previously completed pivotal clinical study PC B305/04 demonstrated reduced recurrence rates for patients with papillary bladder cancer who underwent Hexvix (Cysview) and white light cystoscopy and ...
Eligibility Criteria
Inclusion
- Patients of study PC B305/04 with Ta or T1, that were followed for recurrence are eligible to be included in this study.
Exclusion
- Patient died during clinical study PC B305/04
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
551 Patients enrolled
Trial Details
Trial ID
NCT01166230
Start Date
June 1 2010
End Date
December 1 2010
Last Update
April 9 2019
Active Locations (24)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Cancer Center, Department of Urology
Stanford, California, United States, 94305-5820
2
V.A. Medical Center
Gainesville, Florida, United States, 32608
3
University of Miami School of Medicine
Miami, Florida, United States, 33136
4
South Florida Clinical Research Center, Inc.
Pembroke Pines, Florida, United States, 33028